Clinical trial study of the therapeutic effect of Ivermectin, besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19)

Phase 2

Recruiting

• Conditions: covid-19.; Covid-19, confirmed cases, positive test result; U07.1

• Registration Number: IRCT20200422047168N2
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

People over 18 years old
Real-time PCR test results for SARS-CoV-2 virus were positive after sampling (nasopharynx and oropharynx swab samples)
The manifestations of virus pneumonia in CT scans of their lungs were quite obvious.
Their O2 Saturation percentage were 93% or lower

Exclusion Criteria

History of renal failure
Taking drugs that interfere with Ivermectin
Patients who have been admitted to other clinical trials

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduce the mortality rate of patients with Covid-19. Timepoint: days 0-7. Method of measurement: Based on the percentage of discharged Covid-19 patients.